This site is intended for health professionals only

Vitamin D status shows inconsistent associations with COVID-19 infection

An analysis of data from the UK Biobank revealed no consistent associations between vitamin D status and COVID-19 outcomes

There are no consistent associations between vitamin D status and COVID-19-related outcomes such as diagnosis, hospitalisation and mortality according to the findings of a large cohort study by researchers from Faculty of Epidemiology & Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Vitamin D is known to be essential for bone health and prolonged and severe vitamin D deficiency gives rise to rickets in children and osteomalacia in adults. Furthermore, vitamin D is an immune system modulator that induces an increase in antimicrobial proteins and activity against pathogens. As a result, vitamin D may have a preventative role in infections and one systemic review revealed how supplementation with vitamin D resulted in a small reduction in the risk of acute respiratory infections. However, the role of vitamin D in COVID-19 remains uncertain although according to the results of a 2021 Cochrane review, there is currently insufficient evidence to determine the benefits and harms of vitamin D supplementation as a treatment of COVID-19.

With a lack of good evidence for the association between vitamin D status and COVID-19, for the present study, the UK team used data held within the UK Biobank to better understand this relationship. They included individuals for whom at least one serum vitamin D test was available and levels were categorised as deficient (< 25 nmol/L), insufficient (25 – 49 nmol/L) and sufficient (> 50 nmol/L). The primary outcome of interest was a laboratory confirmed infection with COVID-19 whereas the two main secondary outcomes were the risk of hospitalisation and death as a result of a COVID-19 infection. The team also considered the risk of being diagnosed with COVID-19 when the vitamin D status was assessed, i.e., during the summer and winter months and used the definition of vitamin D sufficiency as the reference point. The analysis was performed using logistic regression after adjustment for covariates which included demographics, body mass index, smoking status and ethnicity.

Vitamin D status and COVID-19 outcomes

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

A total of 307, 512 individuals were included of whom, 46% were deemed to vitamin D sufficient, 41% insufficient and 12% deficient. A total of 10,165 people became infected with COVID-19 with 51.4% of infections reported during autumn, 31% in the winter and only 3.8% in the summer.

Interestingly, during the summer months and in fully adjusted models, participants who were vitamin D deficient had a 14% lower risk of being diagnosed with COVID-19 compared to those who were vitamin D sufficient (Hazard ratio, HR = 0.86, 95% CI 0.77 – 0.95, p < 0.01). In contrast, however, during the non-summer months, the risk of becoming infected with COVID-19 was 14% higher among those who were vitamin D deficient (HR = 1.14, 95% CI 1.01 – 1.30, p = 0.04) though there was no significant association for individuals deemed vitamin D insufficient irrespective of the time of year.

For COVID-19-related hospitalisations, compared to those who were vitamin D sufficient, there was no evidence that any other vitamin D status significantly affected the risk. Similarly, there was no evidence that the risk of COVID-19 mortality was affected by vitamin D levels.

In their conclusion the authors reported that there were inconsistent associations between vitamin D status and a diagnosis of COVID-19 and no clear association between vitamin D levels and either hospitalisation or death.

Citation
Lin LY et al. The association between vitamin D status and COVID-19 in England: A cohort study using UK Biobank PLoS One 2022






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x